VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1062191
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: tested positive for Covid after the vaccine; tested positive for Covid after the vaccine; This is a spontaneous report from a contactable consumer reported for her husband. A 7-decade-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on unknown date at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient received the vaccine and then he tested positive for Covid after the vaccine. The outcome of the events was unknown. Information on Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 1062192
Sex: U
Age:
State:

Vax Date: 01/16/2021
Onset Date: 02/02/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: tested positive for the Covid virus on 02Feb; tested positive for the Covid virus on February 2nd.; This is a spontaneous report from a contactable consumer. This consumer reported similar events for 3 patients. This is 2nd of 3 reports. A 77-year-old patient of unspecified gender received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 16Jan2021 at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Pharmacy technician, calling on behalf of three patients who tested positive after receiving the first dose of the Covid vaccine, asked when they can get the second dose of the Covid vaccine. They received their first dose on 16Jan2021 and tested positive for the Covid virus on 02Feb2021. The outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021138460 same drug/event, different patients

Other Meds:

Current Illness:

ID: 1062193
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Mild soreness at injection site; Myalgia; Tinnitus; This is a spontaneous report from a contactable physician (patient). A patient of unspecified age and gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date (also reported as day 30 following dose 1) at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2 on 29Dec2020 (at the age of 79 years old) at a single dose in the left arm for covid-19 immunization and experienced neurosensory deafness in Rt ear./ total hearing loss in right ear; arm soreness; headache; myalgia; tiredness/episodic fatigue; mild cold intolerance; frontal headache (sinus like); stuffiness/Nasal congestion; postnasal drip and tinnitus in Right Ear. On unspecified date, the patient experienced mild soreness at injection site, myalgia 3/10 on day 1 and tinnitus (bilaterally, left more than right) on day 3 which was persisting but no hearing loss. The patient is scheduled to have an appointment with ENT on 18Feb2021 and will also have antibodies checked. Outcome of the event tinnitus was not recovered while outcome of all the other events was unknown. No follow-up attempts are possible. Information about batch/lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1062194
Sex: F
Age:
State: MI

Vax Date: 01/30/2021
Onset Date:
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Fever; chills; This is a spontaneous report from a Pfizer Sponsored Program from a contactable consumer (patient). A female patient of an unspecified age received the first dose of bnt162b2 (UNSPECIFIED TRADE NAME, Solution for injection, lot/batch number and expiration date not provided), via an unspecified route of administration on 30Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Caller got her first shot last Saturday, then she woke up today with fever and chills (2021). The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1062195
Sex: F
Age:
State: CT

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Swollen lymph nodes (left side of neck, under arm, left chest); Dry mouth; This is a spontaneous report from a contactable consumer (patient). A 26-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot: EL 3247, expiry: unknown), via an unspecified route of administration in the left arm on 27Jan2021 12:45 at a single dose for COVID-19 immunization at a workplace clinic. Medical history included endometriosis, vertigo, pure hypercholesterolemia and allergies to sulfa, orange citrus and almonds. The patient has no covid prior to vaccination. Concomitant medications included ibuprofen (ADVIL [IBUPROFEN]), rosuvastatin calcium (CRESTOR), magnesium, ethinylestradiol, norgestimate (SPRINTEC) and multivitamin. The patient had no other vaccine in four weeks. The patient had PCR test via nasal swab on 04Feb2021 which was negative. The patient experienced dry mouth on 27Jan2021at 13:00 and swollen lymph nodes in the left side of neck, under arm, and left chest on 31Jan2021 at 13:00. The events were not treated. The event dry mouth recovered with sequelae on 31Jan2021 while swollen lymph nodes recovered with sequelae on 07Feb2021.

Other Meds: ADVIL [IBUPROFEN]; CRESTOR; MAGNESIUM; SPRINTEC

Current Illness:

ID: 1062196
Sex: F
Age:
State: IL

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: felt groggy and feverish (highest temp was 100.4) with dizziness and chills and headache all day Friday; dizziness; chills; headache; weird hallucinations; sore arm; felt groggy and feverish (highest temp was 100.4) with dizziness and chills and headache all day Friday; This is a spontaneous report from a contactable nurse, the patient. A 40-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE solution for injection, Lot unknown, second dose) intramuscular in left arm on 28Jan2021 at 09:15 (at the age of 40-years-old) at single dose for COVID-19 vaccination. Medical history and concomitant medications were not reported. Past drug history included allergies: cefazolin sodium (ANCEF). Historical vaccine included BNT162B2 (Lot unknown, first dose) for COVID-19 vaccination on 05Jan2021. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had a sore arm and felt groggy on Thursday night (28Jan2021). The patient was feverish (highest temp was 100.4 F) with dizziness and chills and headache all day Friday, on 29Jan2021. On Friday night (29Jan2021) the patient had weird hallucinations (I hallucinated?, I guess, I was awake and talking to my husband and he said I seemed awake? but that my bed was breaking in half and sinking into the floor, and I kept telling him I couldn't breathe but he said I was breathing normally). No treatment was provided for the events weird hallucinations, sore arm, felt groggy, feverish, dizziness, chills, and headache. The outcome of the events weird hallucinations, sore arm, felt groggy, feverish, dizziness, chills, and headache was recovered on 31Jan2021. Since the vaccination, the patient has not been tested for COVID-19. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: The reported event hallucination was probably related to the use of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) due to temporal relationship. The case will be reassessed should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 1062197
Sex: F
Age:
State: FL

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: tingling sensation left skull; fever 101.8; Mild left arm soreness; This is a spontaneous report from a contactable nurse (patient herself). A 63-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL8982, expiry date: 31May2021), via intramuscular route of administration in the left arm on 15Jan2021 10:05 at a single dose for COVID-19 immunization. Medical history included open cholecystectomy in 1990, hypertension, and sleep apnoea (CPAP). The patient's concomitant medications were not reported. The patient previously received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 22 Dec2020 and experienced fever, nausea, vomiting, diarrhea, metallic taste in mouth, Loss of taste/smell, minimal soreness at the site of injection, strange sensation of tingling in her skull, chills, dry mouth, feels like she has no saliva, tongue felt a little bit too dry, extremely tired, thirst, and altered taste. The patient experienced mild left arm soreness on 15Jan2021 and fever 101.8 on 16Jan2021 23:00. Patient took ibuprofen 400mg and ondansetron (ZOFRAN) 4mg. The patient also experienced tingling sensation left skull continues as described. The patient had no cough, sore throat, stuffy or runny nose. She had no shortness of breath, no nausea vomiting or diarrhea, and no loss of taste/smell or metallic taste in mouth. The patient underwent lab tests and procedures which included body temp: 99.7 on 15Jan2021 18:00, 101.8 on 16Jan2021 11 PM, 99.5 on 16Jan20213 PM, 99.8 on 16Jan2021 10 PM, 99.5 on 17Jan2021 9:00, 99.8 on 17Jan2021 8 PM, 100 on 17Jan2021 10 PM, 99.4 on 18Jan2021 07:00, 99.7 on 19Jan2021 16:00, 98.6 on 20Jan2021 11 AM. Outcome of tingling sensation left skull was not recovered, of remaining events was unknown.

Other Meds:

Current Illness:

ID: 1062198
Sex: M
Age:
State: MA

Vax Date: 02/10/2021
Onset Date: 02/11/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Sore arm; aches; fever; chills; This is a spontaneous report from a non-contactable consumer (Patient). An adult male patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Not available/provided to reporter at the time of report completion), via unknown route of administration on left arm on 10Feb2021 at 17:00 at a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date in Jan2021 on left arm for COVID-19 immunisation. On 11Feb2021 at 12:00 PM, the patient experienced sore arm, fever, chills, aches. The patient assessed the events as non-serious. Events resulted in Doctor or other healthcare professional office/clinic visit. No treatment was received in response to the adverse events. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. The patient not recovered from the events. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1062199
Sex: F
Age:
State: NJ

Vax Date: 01/31/2021
Onset Date: 01/31/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: almost passed out; dizzy; clammy; hot; kept taking my Blood Pressure and pulse ox. Both very, very low; kept taking my Blood Pressure and pulse ox. Both very, very low; This is a spontaneous report from a contactable other healthcare professional. A 56-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot: reported as 96.8), via an unspecified route of administration in the left arm on 31Jan2021 14:15 at a single dose for covid-19 immunization. The patient's medical history included Lupus, Fibro, Hyperthyroidism, Hashimoto's, IBS all from an unknown date. Patient has no known allergies. Concomitant medication included pantoprazole, xylometazoline hydrochloride (SUDAFED [XYLOMETAZOLINE HYDROCHLORIDE]), vitamin c [ascorbic acid], vitamin d3 and calcium (CALCIUM). 15 minutes after the shot while waiting, 8 minutes into it the patient felt dizzy, clammy, hot, and almost passed out. Nurse gave patient oj, oxygen, Epipen, checked sugar, and kept taking her blood pressure and pulse ox. Both very, very low until it came back up within 20 minutes. The patient declined hospital due to feeling better. Called the doctor next day to discuss what happened. She recommended no 2nd shot. The outcome of the events was recovered. The patient has not had Covid prior to vaccination and patient has not tested post vaccination.

Other Meds: PANTOPRAZOLE; SUDAFED [XYLOMETAZOLINE HYDROCHLORIDE]; VITAMIN C [ASCORBIC ACID]; VITAMIN D3; CALCIUM

Current Illness:

ID: 1062200
Sex: M
Age:
State: PA

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: severe prolonged cricopharyngeal spasm; This is a spontaneous report from a contactable physician (patient) A 55-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the right arm on 09Feb2021 at single dose for covid-19 immunisation at hospital. Medical history included rheumatoid arthritis, allergy to penicillin, asthma vaccine, pollen, cats, sea food and latex. Concomitant medication included methotrexate (unknown manufacturer) and methylprednisolone (unknown manufacturer). The patient experienced severe prolonged cricopharyngeal spasm on 09Feb2021 with outcome of recovering. The event resulted in Doctor or other healthcare professional office/clinic visit. No treatment was performed due to the event. The patient did not have COVID-19 prior to vaccination and was not covid tested post vaccination. Information on the lot/batch number has been requested.; Sender's Comments: The Company cannot completely exclude the possible causality between the reported severe prolonged cricopharyngeal spasm and the administration of the COVID-19 vaccine, BNT162B2, based on the reasonable temporal association. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RA, IEC, as appropriate.

Other Meds: METHOTREXATE; METHYLPREDNISOLONE

Current Illness:

ID: 1062201
Sex: F
Age:
State:

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: body aches; headache; chills; arm soreness; This is a spontaneous report from a non-contactable consumer (patient). A 27-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on Feb2021 at single dose for covid-19 immunization. Vaccine location was left arm and it was the second dose. Patient received the first dose of vaccine on Jan2021 12:00 PM for covid-19 immunization on the left arm, also at age of 27-year-old. The most recent COVID-19 vaccine facility type was Workplace clinic. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine nor received any other medications within 2 weeks of vaccination. The patient medical history and concomitant medications were not reported. The patient experienced body aches, headache, chills, arm soreness on Feb2021 with outcome of unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1062202
Sex: F
Age:
State: CA

Vax Date: 02/10/2021
Onset Date: 02/10/2021
Rec V Date: 03/01/2021
Hospital: Y

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: rash; a bit nauseous; I felt tingling my tongue; light headed; top of my palate strange; taste of metal in my mouth; swelling; inside of mouth swelling; loss of vision; something weird on liver; lumps on skin; kidney is hurting; vaccine took away all the depression; This is a spontaneous report from a contactable consumer (the patient). A 67-year old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 10Feb2021 (at the age of 67-years-old) for COVID-19 immunization. Medical history included high blood pressure, glaucoma and depressed from an unknown date. Concomitant medications were not reported. The patient had taken 10mg of antihistamine around 30 minutes before the vaccine (unspecified). The patient previously took iodine and experienced allergic reaction and flu vaccine and had an allergic reaction. On 10Feb2021, the moment they finished putting the shot, the patient experienced rash, nausea, swelling, tingling on the tongue, palette and inside of mouth, top of palate strange, metal taste, and light headed (felt like she was flying). The patient was hospitalized for the events rash, nausea, swelling, tingling on the tongue, palette and inside of mouth, top of palate strange, metal taste, felt nauseous, and light headed on an unknown date. The patient experienced a loss of vision reported as she cannot read her computer because the letters are gray; something weird on her liver, has lumps on her skin and kidney is hurting on an unknown date. The patient also experienced the vaccine took away all the depression and has made her active, now does everything and has been super positive, feels her internal battery is full. The clinical outcome of the events rash, nausea, paraesthesia oral, dizziness, palatal disorder, dysgeuisia, swelling, mouth swelling, blindness, liver disorder, skin swelling, renal pain and therapeutic response unexpected was unknown. The batch/lot numbers for the vaccine, PFIZER-BIONTECH COVID-19 MRNA VACCINE, were not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1062203
Sex: F
Age:
State: GA

Vax Date: 02/01/2021
Onset Date: 02/03/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Took benadryl for injection site inflammation; Swelling; Itching; heat at injection site occurring over the week post-injection; Knot; diarrhea which is like I had when I had Covid last fall.; This is a spontaneous report from a non-contactable consumer (patient). A 66-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EL3249), on 01Feb2021 at 15:00 (at the age of 66-years-old) at single dose in left arm for COVID-19 immunisation. The patient was vaccinated at Doctor's office/urgent care. No other vaccine was given within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Other medical history included irritable bowel syndrome (IBS), and high blood pressure. Concomitant medications included linsinopril, estradiol, naproxen sodium (ALEVE), tocopherol (VIT. E), colecalciferol (VITAMIN D), multivitamin. On 03Feb2021 the patient experienced swelling, itching, knot, heat at injection site occurring over the week post-injection, injection site inflammation, as well as diarrhea which is like she had when had Covid last fall. The events resulted in emergency room/department or urgent care. As treatment received it was reported the patient took Benadryl for injection site inflammation. The events were resolving. Since the vaccination, the patient has not been tested for COVID-19. No follow-up attempts are possible. No further information is expected.

Other Meds: LISINOPRIL; ESTRADIOL; ALEVE; VIT. E; VITAMIN D

Current Illness:

ID: 1062204
Sex: F
Age:
State: MA

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: fatigue; worse sore arm; This is a spontaneous report from a contactable consumer (patient's father). A 21-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; batch/lot number and expiration date were unknown), via an unspecified route of administration in the left arm on 07Jan2021 at 15:00 at a single dose for COVID-19 immunization. The vaccination facility type was reported as the hospital. The patient previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; batch/lot number and expiration date were unknown) on 17Dec2020 for COVID-19 immunization and experienced arm was kind of sore and she was pretty tired, for which no admission to the hospital was involved and the patient did not receive any treatment. The patient's medical history was not reported. There were no concomitant medications. There were no other products taken together with the vaccine. The patient experienced worse sore arm on 07Jan2021 at 20:00 and experienced fatigue the next day on 08Jan2021 at 08:00. The adverse events (AEs) did not require any visit to an emergency room or a physician office. The patient did not receive any treatment for the events. The patient recovered from the event "worse sore arm" on an unspecified date, while the outcome of the event "fatigue" was unknown. Information on the batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 1062205
Sex: F
Age:
State: NC

Vax Date: 02/04/2021
Onset Date: 02/04/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: she may have been panicked; she already has a pre-existing cardiac arrhythmia, but it seemed to have gotten worse after receiving the 1st dose/More arrhythmia problems; she already has a pre-existing cardiac arrhythmia, but it seemed to have gotten worse after receiving the 1st dose/More arrhythmia problems; left arm soreness; she felt ugh, like she was getting sick; sensation like she was going to pass out; Headache; This is a spontaneous report from a contactable nurse (patient). This 43-year-old female patient female received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Lot number EM9810, intramuscular on left deltoid on 04Feb2021 as single dose (at the age of 43 years) for Covid-19 Immunization. No medical history reported, and no concomitant medication reported. Historical vaccine included BNT162B2 for Covid-19 Immunization. Medical history included Pacemaker in Jun2019 and ongoing, sick sinus syndrome, and pre-existing cardiac arrhythmia ongoing. Historical vaccine included Tetanus, Tetanus made her arm sore, the soreness from tetanus was worse than the soreness from COVID vaccine since it lasted a week with tetanus, no lot number reported. No concomitant medication was reported. The patient experienced she already has a pre-existing cardiac arrhythmia, but it seemed to have gotten worse after receiving the 1st dose/More arrhythmia problems on 05Feb2021 considered medically significant with outcome of not recovered, Within 15 minutes after receiving the vaccine she felt like she was going to pass out three times on 04Feb2021 considered medically significant and recovered on 04Feb2021, she may have been panicked on unspecified date with outcome of unknown, left arm soreness on 05Feb2021 with outcome of recovered on Feb2021, and she felt ugh, like she was getting sick on 05Feb2021 with outcome of unknown. The patient did not receive treatment for events. She stayed an extra 30 minutes to be monitored after the initial waiting of 15 minutes since she had to drive home, then she felt better. She has not called her cardiologist since she has the history of arrhythmias. She had the more arrhythmias start on the evening of the 05Feb2021, states it was weird because it seems to happen more in the evening between 6 and 9pm, sometimes as late as 10pm. However, 'yesterday' it started happening during the day, and it is more frequent, not constant, it just happens. States it is hard not think about it when her heart is having hiccups since that is what it feels like. She knows what it feels like because when her pacemaker goes off ventricularly she can feel it. She had arrhythmias before the vaccine but has not had issues with arrhythmias continuously. She was diagnosed with sick sinus syndrome and they do not know if it is cardiology or neurology, states it has been an issue for her for the last two years (2019). Lab data included weight of 284-286. She is asking if there is any data that supports her getting the second dose on 25Feb2021. She has read that some people tend to have more side effects with the second dose. The patient had no prior vaccinations (within 4 weeks).; Sender's Comments: Based on vaccine-event chronological association, a causal relationship between events worsening arrhythmia and pre-syncope and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness: Cardiac arrhythmia; Pacemaker insertion (cardiac)

ID: 1062206
Sex: F
Age:
State:

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: really high blood sugar, some mornings over 300 mg; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unknown date in Feb2021 (a week ago) as a single dose for COVID-19 vaccination. Medical history included ongoing diabetic from an unknown date. Concomitant medications were not reported (reported she takes 'sugar medicine' for diabetes). In Feb2021, since receiving the vaccine, the patient experienced sugar levels have been high, the first 3 or 4 days they were really high, some mornings they were over 300mg. The patient underwent lab tests which included sugar levels which showed over 300mg on an unknown date. The patient was treated for the blood sugar high with taking half of her sugar medicine. The clinical outcome of the event blood sugar increased was recovering reported as the levels were lowering a little. The batch/lot numbers for the vaccine, PFIZER-BIONTECH COVID-19 MRNA VACCINE, were not provided and will be requested during follow up.

Other Meds:

Current Illness: Diabetic (takes sugar medicine)

ID: 1062207
Sex: M
Age:
State: MI

Vax Date: 02/08/2021
Onset Date: 02/12/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Flu like symtoms; chill; sligh headache; a little tired; This is a spontaneous report from a contactable other hcp (patient). A 74-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EM9810), via an unspecified route of administration on 08Feb2021 09:45 at single dose for covid-19 immunization. Vaccine location was left arm and it was the second dose. Patient received the first dose of vaccine on an unknown date for covid-19 immunization. Patient was not diagnosed with COVID-19 prior to vaccination nor tested for COVID-19 since the vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient medical history and concomitant medications were not reported. The patient experienced flu like symtoms, chill, sligh headache, temp at 97.8 and a little tired on 12Feb2021 09:00 AM. Patient didn't receive treatment for the adverse events. The outcome of events was unknown. The events were reported as non-serious.

Other Meds:

Current Illness:

ID: 1062208
Sex: F
Age:
State: IL

Vax Date: 02/02/2021
Onset Date: 02/06/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: brain fog; Bell's palsy on left side of face; vision has been off/ Vision is blurry; Numbness and tingly/burning sensation in right leg; Numbness and tingly/burning sensation in right leg; Numbness and tingly/burning sensation in right leg; This is a spontaneous report from a contactable consumer (patient). A 33-year-old female patient received the first dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EL9264 and Expiration Date: May2021), via an unspecified route of administration in the left arm on 02Feb2021 at 17:45 at 33-years-old at a single dose for COVID-19 immunization; with no other vaccines administered within four weeks of the bnt162b2 administration. Medical history included anxiety from an unknown date and unknown if ongoing. Concomitant medications included alprazolam (XANAX) taken for an unspecified indication from an unspecified date to an unspecified date, prednisone (MANUFACTURER UNKNOWN) taken for an unspecified indication from an unspecified date to 16Feb2021. The patient experienced the following events and outcomes: Bell's palsy on left side of face (medically significant) on 06Feb2021 12:00 with outcome of recovering, vision has been off/ vision is blurry (medically significant) on 06Feb2021 12:00 with outcome of recovering, numbness and tingly/burning sensation in right leg (medically significant) on 06Feb2021 12:00 with outcome of recovering, brain fog (medically significant) on an unspecified date with outcome of unknown; all of which required a physician office visit. The clinical course was reported as follows: The patient received the first dose of the Pfizer COVID 19 vaccine, she began having symptoms on the following Saturday and was seen by her doctor and diagnosed with Bell's Palsy. The patient stated she has reported this via VSafe and the Pfizer website. The patient also reported other symptoms that have not been reported as follows: had tingling in both legs, brain fog, and vision has been off. The patient was not sure if it was related to the vaccine or steroids. The patient wanted to know if she should get the second dose. The patient had been on a steroid, so she did not know if she should wait to get the second dose. The patient just stopped the steroid on 16Feb2021, and the second dose was scheduled for 23Feb2021. The patient also said she had other symptoms that she had not reported and she said she had tingling that started in one leg now in both legs, brain fog and her vision was off and she was not sure if that was related to the vaccine or the steroid (later clarified as prednisone). The patient was not taking the steroids at the time of diagnosis. "Correct I mean it started after the vaccine, but I was also on medication (Clarified as Prednisone) so I am not really sure what the difference is at this time." Treatment in response to event: the patient stated, "No I mean for the tingling in my leg I have been just putting heat and Ice on it but I have not done anything actual big treatment and then for my eyes no, my doctor is not sure what is related to the Bell's Palsy and what is to medication." The patient underwent lab tests and procedures which included lab work: unknown result on an unspecified date (patient stated, "Yes, I have many"). Therapeutic measures were taken as a result of facial paralysis, hypoaesthesia, burning sensation, and paraesthesia; which included steroids and anti-viral and anti-nausea medicine. The patient did not have COVID prior to the vaccination. The patient was not tested for COVID post vaccination.

Other Meds: XANAX; PREDNISONE

Current Illness:

ID: 1062209
Sex: F
Age:
State:

Vax Date: 02/11/2021
Onset Date: 02/11/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: lady who injected the patient was a little upset since it bleed a little after being injected; bruise on her arm/Injection site bruising; she felt a little light headedness; little nauseated; Slight 'tenderness'; This is a spontaneous report from a contactable consumer (female). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot and expiry not reported), as second dose via an unspecified route of administration on the arm on 11Feb2021 at single dose for covid-19 immunization. Medical history included slow clotting problem (when she was little/was never diagnose with a disorder) and first vaccination (she did not have any bruise). The patient's concomitant medications were not reported. It was reported that the patient had the second dose of the Pfizer COVID-19 vaccine yesterday (11Feb2021). The lady who injected the patient was a little upset since it bleed a little after being injected. The patient stated, "You are very good that did not hurt. She said not that good. You are bleeding. You should not be bleeding but I do not even know she said you should not be bleeding but she said and then she kept patting my arm on the spot that it was, where she injected me and she said yeah that is right where I should inject you". The patient said that she was fine and was not concerned with the AEs but she wanted to know if the vaccine was still effective even though she bled. She also said that she developed a pretty big bruise on her arm/injection site bruising. The patient was injected in the deltoid muscle. She said when she removed the band aid there was only little blood transferred there. The patient said that her doctor when she was little told her that she has a slow clotting problem but was never diagnose with a disorder. The patient said that she felt a little light headedness or a little nauseated after being injected. The patient's concerns were not to the bruising, did not concern her at all. Her main concern was to make sure that she did not have symptoms and she wondered afterwards, the patient ended consoling her. The lady was concerned that may be the patient was on blood thinners. The patient said that she was not on blood thinners. The patient had a slight 'tenderness' never really caused her a problem. Just breathe a little bit easier and when she got home and took off the Band-Aid there was really hardly any blood there but she had the first vaccination she did not have any bruise. The patient have a huge bruise on her arm this time and that was okay. The patient bruise equally too. But she just wanted to make sure that since they really did not have symptoms that the vaccine was really injected into the area where it was going to be affected for her. The patient assessed the case as non-serious. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1062210
Sex: F
Age:
State: TN

Vax Date: 02/11/2021
Onset Date: 02/01/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Feet felt stiff and bone in right leg felt strange; Feeling dizzy and faint like; tired; Sinuses started to drain; itching on the right shoulder (where she had the vaccine); Itching on right side of arm near elbow, middle part of stomach and neck; pain in the shoulder; This is a spontaneous report from a contactable consumer, the patient. AN 80-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EN6201, Expiry date: 30Jun2021) intramuscularly in the right arm on 11Feb2021 at 13:00 (at the age of 80-years-old) as a single dose for COVID-19 immunization. Medical history included highly sensitive and highly allergic to everything from food to medicine; had been through near death with allergies; allergic to penicillin, iodine and shellfish; high blood pressure, eye disorder (unspecified), allergies with her sinuses. Concomitant medications were not reported, but the patient took unspecified high blood pressure and eye medication. The patient previously took dextropropoxyphene hydrochloride (DARVON), ether and castor oil and experienced allergies; sulfamethoxazole and trimethoprim (BACTRIM) for severe acute sinusitis on Jan2021 (about a month ago). On 11Feb2021 at 13:20, the patient start feeling dizzy and faint like, and felt a little tired. She came home and went to bed and on 11Feb2021, had itching on the right shoulder (where she had the vaccine) and on the right side of the arm near the elbow, the middle part of the stomach and the neck (itching came and went) and later, her sinuses started to drain. On 12Feb2021, the patient's feet felt stiff and the bone in the right leg felt strange. On an unspecified date in Feb2021, the patient had pain in the shoulder. The patient queried if she can take aspirin for the pain in the shoulder and diphenhydramine (BENADRYL) if the itching comes back. The clinical outcome of pain in the shoulder was unknown, of "itching on right side of arm near elbow, middle part of stomach and neck", "feeling dizzy and faint like", tired, sinuses started to drain, "feet felt stiff and bone in right leg felt strange" and "itching on the right shoulder (where she had the vaccine)" was resolving.

Other Meds:

Current Illness:

ID: 1062211
Sex: M
Age:
State: NV

Vax Date: 01/28/2021
Onset Date: 02/12/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Fever / He was at a feverish point; his body was warm and getting warmer and warmer; sweating; Chills; This is a spontaneous report from a contactable consumer reporting for himself. This 75 years old male consumer received the first single dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot EL9261) on 28Jan2021 at 09:50, in left arm, for COVID-19 immunisation. The patient was a disable war veteran; the Military gave him the COVID vaccine. Medical history included malaria (and another unspecified condition during his military service, they used "IVs to bring him back" and he even had a spinal tap, he was also in "a coma, on his way out to the next" and they said he was shaking like a leaf on the tree), skin problems (he had already been under the (government organization) care of malaria and skin problems), prostate problems, back problems since the war, he was still in a back brace for his back problems (he had been wearing it since the 60's), major spinal surgery in Mar2019 where his L1 and L5 were taken out (he lost a lot of fluid as a result of this surgery). Since they took his L1-L5, he had no real body control of his lower extremities and due to this he was awarded money from the (government organization). The patient received an unspecified influenza vaccine in the past, on an unknown date, for immunization. Concomitant medications were not reported. On 12Feb2021 at 03:30 AM, the patient experienced fever, he described his body was warm and getting warmer and warmer and was sweating. He was at a feverish point, his sheets he was sweating and wet from his back to feet. He also had chills. He got up thinking this reaction was from the COVID vaccine, he had an Enurse drink in his fridge and took powdered acetylsalicylic acid (ASPIRIN) and then he laid there and let his body go through the changes. He knew that his body can recover from heat. He went to sleep, woke up and had no more chills; he was sweating, but it was gone, his body was normal, he was under the covers. It was like how his normal body just took it like penicillin, it did the same thing. The events resolved on 12Feb2021 at 07:00 AM. His second vaccine dose was schedule on 18Feb2021 at 9:50 AM.

Other Meds:

Current Illness: Brace user (for his back problems, wearing it since the 60's); Disability

ID: 1062212
Sex: M
Age:
State:

Vax Date: 02/11/2021
Onset Date: 02/11/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: a nursing student took out the needle and watered down vaccine came out with blood (not typical); a nursing student took out the needle and watered down vaccine came out with blood (not typical); This is a spontaneous report from a contactable consumer (patient). A 58-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular on 11Feb2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient called regarding an incident that took place yesterday (11Feb2021) at the vaccine center. The patient asked about a loss of vaccine when an injection causes bleeding. He went to a hospital and a nursing student took out the needle and the vaccine came watering down with blood which was not typical. He was asking what should be done on this case, if there were any cases like this, how much vaccine came out, and if it required re-vaccination. It was given intramuscularly, but however when the needle was removed, a little geyser of blood came out of the hole. That's where the question lies, he asked if he needs to be concerned. The only person who would have that information would be Pfizer or CDC. His physician was not educated regarding this. He was asking about the loss of vaccine when there's bleeding and what to do. He was a journalist and thought it would be better if a scientist who can answer and give an answer more directly would speak to him. He already has part of this written up and will publish this. He wanted more information regarding this. He believes more people have experienced this and there was more information available for this. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1062213
Sex: F
Age:
State: NC

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: needle was removed from arm, blood streamed down her arm about 5-6 inches; This is a spontaneous report from a contactable consumer (husband reporting for wife). This 68-year-old female patient female received dose 2 of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Lot number EN6201, unspecified route in arm on 09Feb2021 as single dose (at the age of 68 years) for Covid-19 Immunization. No medical history reported, and no concomitant medication reported. Historical vaccine included BNT162B2 for Covid-19 Immunization. The patients husband reported when the needle was removed from his wife's arm, blood streamed down her arm about 5-6 inches on 09Feb2021. The doctor who removed the needle immediately put a round bandage on the injection site and then the stream stopped but before there was a steady stream of blood running down her arm. Patient's husband is wondering if she could have lost any of the vaccine when this happened. The caller would like to know if there is any possibility the vaccine might have come out in the blood. Patient's husband heard the first dose given in (name of city) had leaking from the syringe prior to injection and was an invalid dose. Patients husband reported "the doctor who did the vaccine did put the needle all the way in and pushed the plunger all the way in." Patient's husband is wondering about how much vaccine is remaining for his protection and the potential need for revaccination. Outcome of event needle was removed from arm, blood streamed down her arm about 5-6 inches was unknown.

Other Meds:

Current Illness:

ID: 1062214
Sex: F
Age:
State: NH

Vax Date: 02/11/2021
Onset Date: 02/11/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: light headed and dizzy, mild; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received first single dose of BNT162B2 (Pfizer, solution for injection, lot number: EL3247, exp date not reported), via an unspecified route of administration (vaccine location: right arm) on 11Feb2021 10:30 to 11Feb2021 10:30 at SINGLE DOSE for COVID-19 immunisation. Facility where the most recent COVID-19 vaccine was administered: Workplace clinic. The patient had no relevant medical history. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Patient had no allergies to medications, food, or other products. There was no other medication received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There was no other medication received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced light headed and dizzy, mild; lasted day of injection on 11Feb2021 16:00. The event was considered as non-serious by the reporter. No treatment received for the adverse event. Since the vaccination, the patient had not been tested for COVID-19. The patient recovered from the event on an unspecified date in Feb2021.

Other Meds:

Current Illness:

ID: 1062215
Sex: M
Age:
State: NY

Vax Date: 02/05/2021
Onset Date: 02/05/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: anaphylactic reaction with tightness around his jaw area, ears, and throat, and tightness in upper chest that lasted intermittently for 4 days; anaphylactic reaction with tightness around his jaw area, ears, and throat, and tightness in upper chest that lasted intermittently for 4 days; anaphylactic reaction with tightness around his jaw area, ears, and throat, and tightness in upper chest that lasted intermittently for 4 days; anaphylactic reaction with tightness around his jaw area, ears, and throat, and tightness in upper chest that lasted intermittently for 4 days; This is a spontaneous report from a contactable consumer (the patient). A 75-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9264), via an unspecified route of administration on 05Feb2021 at 11:10 AM (at the age of 75 years), as a single dose for COVID-19 immunization. Medical history included kidney transplant. Concomitant medication included tacrolimus, mycophenolate mofetil (MYCOPHENOLATE), prednisone. Historical vaccine included Dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL8982), on 14Jan2021 for COVID-19 immunization). On 05Feb2021 at around 18:00 PM, the patient had what he believed was an anaphylactic reaction with tightness around his jaw area, ears, and throat, and tightness in upper chest (he clarified that upper chest as where the neck meets the chest. It may have been a little lower, but not that far down that he would have worried. It was the upper chest where the neck meets the chest. Not in the chest to the left or right). It lasted intermittently for 4 days. He reported that it was not continuous, it would come for 2-3 hours dissipate and then come again. It wasn't all day and all night. He reported "I'm better now". The clinical outcome of anaphylactic reaction with tightness around his jaw area, ears, and throat, and tightness in upper chest was recovered on 10Feb2021.

Other Meds: TACROLIMUS; MYCOPHENOLATE; PREDNISONE

Current Illness:

ID: 1062216
Sex: F
Age:
State: MN

Vax Date: 02/03/2021
Onset Date: 02/11/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Induration/3 inch diameter raised injection site; hot very red, itchy; hard area around it; Induration/3 inch diameter raised injection site; hot very red, itchy; hard area around it; Induration/3 inch diameter raised injection site; hot very red, itchy; hard area around it; Induration/3 inch diameter raised injection site; hot very red, itchy; hard area around it; Induration/3 inch diameter raised injection site; hot very red, itchy; hard area around it; This is a spontaneous report from a contactable consumer (patient). A 76-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9262; Expiration date was not reported) on 03Feb2021 (12:15) at a single dose on the right arm, with route of administration unspecified, for COVID-19 immunization at the physician's office. Medical history included vulvodynia; back issues; sulfa allergy; penicillin (PCN) allergy; and allergy to "mycins". Concomitant medication included estrogens conjugated (PREMARIN) and propranolol. The patient previously took morphine sulfate, and had drug allergy; lansoprazole (ZOLANAS), and had drug allergy; and tetanus vaccine, and had allergy to the vaccine. The patient was not pregnant at the time of vaccination. On 11Feb2021 (16:30), the patient had induration/3-inch diameter raised injection site that was hot, very red, itchy and hard around it. The reported events resulted into physician's office visit. The patient did not receive any treatment for the reported events. The outcome of the events, 'induration/3-inch diameter raised injection site that was hot, very red, itchy and hard around it', was recovering. The patient was not diagnosed with COVID-19 prior to the vaccination, and had not been tested since the vaccination.

Other Meds: PREMARIN; PROPANOLOL

Current Illness:

ID: 1062217
Sex: F
Age:
State: PA

Vax Date: 02/05/2021
Onset Date: 02/08/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: severe glaucoma; Intermittent itching, numbness around my left eye & down cheek; Intermittent itching, numbness around my left eye & down cheek; Visual field defect; Intermittent itching, numbness around my left eye & down cheek; Intermittent itching, numbness around my left eye & down cheek; This is a spontaneous report from a contactable consumer. A non-pregnant 71-year-old female patient received the first dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number EM9810), via an unspecified route of administration in the right arm on 05Feb2021 at 15:30 at 71-years-old at a single dose for COVID-19 immunization. The patient did not receive any other vaccine within four weeks of the bnt162b2 administration. Medical history included controlled blood pressure high (HBP) from an unknown date and unknown if ongoing, glaucoma from an unknown date and unknown if ongoing; "known allergies: comparing." Concomitant medications included unspecified medications taken for an unspecified indication from an unspecified date to an unspecified date; within two weeks of the vaccination. On 08Feb2021 at 07:30, the patient experienced: severe glaucoma (medically significant), intermittent itching, numbness around my left eye & down cheek (non-serious), visual field defect (non-serious); with no treatment received. The clinical outcome of the events was not recovered. The patient was not tested for COVID prior to the vaccination and post vaccination.

Other Meds:

Current Illness:

ID: 1062218
Sex: M
Age:
State: VA

Vax Date: 02/10/2021
Onset Date: 02/12/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: seizure; unresponsive for 20 minutes; This is a spontaneous report from a contactable physician reporting for himself. A 93-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number/expiration date: not provided), via an unspecified route of administration, on 10Feb2021 at 15:45 (at the age of 93 years old) as a single dose for COVID-19 IMMUNIZATION. Relevant medical history included dementia from an unknown date. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number/expiration date: not provided), via an unspecified route of administration, on 21Jan2021 (at the age of 93 years old) as a single dose in the deltoid right for COVID-19 IMMUNIZATION. The patient did not have any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included atorvastatin and levothyroxine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 12Feb2021 at 13:30, the patient experienced a seizure and was unresponsive for 20 minutes. Treatment for the events included careful observation and airway protection. The outcome of the events seizure and unresponsive was recovered on an unspecified date in Feb2021. Since the vaccination, the patient had not been tested for COVID-19. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Seizure and Unresponsive to stimuli cannot be excluded. The case will be reassessed if additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: ATORVASTATIN; LEVOTHYROXINE

Current Illness:

ID: 1062219
Sex: F
Age:
State: CT

Vax Date: 01/14/2021
Onset Date: 01/01/2021
Rec V Date: 03/01/2021
Hospital: Y

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: MRI showing inflammatory lesion of the Pons/Single lesion appearing inflammatory in nature found in the pons at origin of cranial nerve 6; single lesion appearing inflammatory in nature found in the Pons at origin of Cranial Nerve 6; Development of double vision/double vision with right gaze and head turning; mild chills; headache; significant diarrhea; vision noted to be off; This is a spontaneous report from a contactable other health care professional, the patient. A 41-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EL1283), via an unspecified route of administration on 14Jan2021 at 01:15 (at the age of 41-years-old) as a single dose in the left arm for COVID-19 vaccination. Medical history included spontaneous coronary artery dissection with stenting (reported as "five years ago") and complex migraines from an unspecified date. The patient is allergic to Tramadol, Codeine and Novocaine. The patient's historical vaccinations included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EH9899) on 23Dec2020 at 01:15 AM as a single dose in the left arm for COVID-19 immunization.The patient was not pregnant at the time of vaccination. The vaccination was administered in a hospital. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included diltiazem (MANUFACTURER UNKNOWN), acetylsalicylic acid (ASPIRIN).The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient reported the development of double vision on 25Jan2021 at 06:00. She was hospitalized and remained hospitalized for three days. She reports having had an MRI (date not specified) which showed an inflammatory lesion of the Pons. She further described the events as follows: Initially mild chills and headache "the day after" developing into significant diarrhea for four days and on and off diarrhea for several weeks. One week after vaccine vision noted to be off but no official work up developing into double vision with right gaze and head turning three weeks after vaccine. She also stated that there was a single lesion appearing inflammatory in nature found in the Pons at origin of Cranial Nerve 6. Treatment received included Solumedrol and Pepcid infusion. Lab data included an MRI on an unspecified date which showed inflammatory lesion of the Pons and COVD-19 testing as follows: SARS-CoV-2 Nasal Swab PCR test on 20Jan2021 and on 11Feb2021 both of which were negative. The clinical outcomes of brain inflammation, double vision, chills, headache, diarrhea, vision decreased and cranial nerve disorder were reported as recovering. No follow-up attempts are possible. No further information expected.; Sender's Comments: Based on vaccine-event chronological association, a causal relationship between reported events and BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: DILTIAZEM; ASPIRIN

Current Illness:

ID: 1062220
Sex: M
Age:
State: MA

Vax Date: 01/27/2021
Onset Date: 02/12/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: positive COVID-19 test with symptoms; positive COVID-19 test with symptoms; This is a spontaneous report from a contactable consumer (patient). A 44-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL3247), via an unspecified route of administration in left arm on 27Jan2021 11:00 (at age 43-years-old) at a single dose for COVID-19 immunization. Medical history included blood pressure. The patient did not have COVID prior vaccination. No known allergies. Concomitant medications included atorvastatin (LIPITOR), amlodipine besilate (NORVASC), sildenafil citrate (VIAGRA), and amfetamine sulfate (AMPHETAMINE SALTS). The patient tested positive for SARS-CoV-2 on 12Feb2021, patient was symptomatic (cough, diarrhea, headache) since 06Feb2021. Covid test post vaccination via Nasal Swab, (NAAT Aptima SARS-CoV-2 assay) on 12Feb2021 with covid test result Positive. Treatment received included Aspirin. The outcome of the events was not recovered.

Other Meds: LIPITOR [ATORVASTATIN]; NORVASC; VIAGRA [SILDENAFIL CITRATE]; AMPHETAMINE SALTS

Current Illness:

ID: 1062221
Sex: M
Age:
State: VA

Vax Date: 02/12/2021
Onset Date: 02/13/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: passed some blood when he went to the bathroom; fever of 100 degrees; This is a spontaneous report from a contactable consumer, the patient. A male patient of an unknown age (reported as 73 with no units provided) received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on 12Feb2021 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 13Feb2021, the patient passed some blood when he went to the bathroom and had a fever of 100 degrees Fahrenheit. The clinical outcomes of the passed some blood when he went to the bathroom and fever were unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1062222
Sex: F
Age:
State: IN

Vax Date: 02/02/2021
Onset Date: 02/02/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Trouble breathing; nausea; severe headache/excruciating headache; Feeling generally unwell to the point I almost went to the emergency room/terribly unwell feeling; This is a spontaneous report from a contactable consumer (patient). A 72-years-old non-preganant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot EN5318, via an unspecified route of administration on 02Feb2021 15:45 (at the age of 72 years old) for COVID-19 vaccination, Unspecified other vaccine (Pfizer) on 02Feb2021, dose number in the left arm for an unspecified indication.Medical history included asthma from an unknown date and unknown if ongoing (asthma under control), pancreatitis chronic from an unknown date and unknown if ongoing (Occasional chronic pancreatitis), Blood pressure from an unknown date and unknown if ongoing, drug allergies from an unknown date and unknown if ongoing. Concomitant medication included Blood pressure medication. The patient previously took morphine and experienced allergies morphine and sulfa and experienced allergies sulfa. The patient received the vaccination at the hospital. On 02Feb2021, the patient felt as if she was having a heart attack. On 02Feb2021, the patient had trouble breathing, nausea, and severe headache. On 02Feb2021, the patient was felling generally unwell to the point she almost went to the emergency room. The excruciating headache and terribly unwell feeling has lasted well over 10 days. No treatment was received for the events. Outcome of the events was recovering. The patient did not have covid prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 1062223
Sex: F
Age:
State: VA

Vax Date: 02/07/2021
Onset Date: 02/01/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: not thinking straight; very very intense headache; felt an ungodly pressure in my head; My vision was off; foggy; confused; coughing; felt severe tightness in left side of my chest and that moved to the center of my chest and started to like move up higher, more towards my throat and then it stopped; severe tightness in left side of my chest and that moved to the center of my chest and started to like move up higher you know more towards my throat; rapid heart rate, 100bpm and 102bpm and lasted for couple of days.; my head was more clear but still had some pressure and woozy; Trouble concentrating; ALT High; Test: Cholesterol; Result: Little High/Cholesterol 207 was high; This is a spontaneous report from a contactable consumer, the patient. A 67-years-old female received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EL9269), via an unspecified route of administration on 07Feb2021 (at the age of 67-years-old) as a SINGLE DOSE for Covid-19 Vaccination. Medical history included ongoing asthma, type 2 diabetes mellitus, seasonal allergy (told to take Zyrtec for seasonal allergies prophylactically). Facility in which the vaccine was received was a clinic at a high school through the local hospital. Concomitant medication included fluticasone propionate, salmeterol (WIXELA INHUB), glipizide (GLIPIZIDE). On 07Feb2021, the patient received the first dose and while walking to the observation area (about two minute after receiving the vaccine) the patient experienced very very intense headache, felt an ungodly pressure in my head, vision was off, and trouble concentrating. When she sat down got real foggy, confused and was not thinking straight, was coughing and experienced severe tightness in left side of my chest and that moved to the center of my chest and started to like move up higher, more towards my throat and then it stopped. Patient began taking deep breath. It went back over to left side of my chest and the tightness (stayed in my left chest for probably 3 days but not to the same degree). The fogginess and the intense pressure in my head, it was bad to the point she thought she would not be able to drive home, waiting for 30 minutes, and because she was not thinking clearly she didn't even ask anybody for help. When she got to the car she waited 15 minutes more before driving home. Patient stayed like this for 2 days. When she reached home, she experienced a rapid heart rate, 100bpm and 102bpm and lasted for couple of days. Each day got gradually better, her head was clearer but still had some pressure and woozy. The patient did visit the physician, he did an EKG and other test. The doctor did not think what I had was an anaphylaxis reaction. Physician recommended she make sure to take her inhalers, for asthma and told me to take Zyrtec (for seasonal allergies) ahead of time. Consumer inquired if she should receive the second dose. The patient underwent lab tests and procedures which included blood cholesterol: little high 207 on Feb2021, blood thyroid stimulating hormone: normal on Feb2021, electrocardiogram: normal on Feb2021, full blood count: normal on Feb2021, hemoglobin: 6.9 on Feb2021, heart rate: 100 bpm on Feb2021, heart rate: 102 bpm on Feb2021, metabolic function test: Alt high on Feb2021. No treatment was given for the events. The clinical outcome of the events not thinking straight, pressure in my head, foggy, confused, coughing, tightness in the left side of my chest , it then moved to the center of my chest then moved up towards throat, rapid heart rate, Woozy, intense headache, vision was off and trouble concentrating was recovering while ALT High, and Cholesterol; Result: Little High was unknown.

Other Meds: WIXELA INHUB; GLIPIZIDE

Current Illness: Asthma

ID: 1062224
Sex: F
Age:
State:

Vax Date: 01/25/2021
Onset Date:
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: loss of hearing; ear pains; This is a spontaneous report from a contactable consumer, the patient. This female patient of unknown age (reported as (age: 80 unit: unspecified) received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: unknown), dose 1, single dose via an unspecified route of administration on 25Jan2021 for COVID-19 vaccination. Medical history was not reported. Concomitant medications were not reported. On an unknown date in 2021, the patient had ear pain and loss of hearing. The events were reported as non-serious. The clinical outcome of ear pain and loss of hearing was unknown. The reporter was unsure if the events were related. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1062225
Sex: F
Age:
State: IL

Vax Date: 02/01/2021
Onset Date: 02/05/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: eyelids became puffy; eyes became glassy; fever; body aches; chills; bad headaches; implanted breast skin became blotchy; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: E63247) , via an unspecified route of administration in the right arm on 01Feb2021 at 15:00 (at the age of 70-years-old) as a single dose for COVID-19 immunization. Medical history included Raynaud's syndrome, chronic lymphocytic leukaemia, irradiated thyroid gland, high cholesterol, previous breast cancer, allergy to latex and adhesives, and breast implants. Concomitant medications included levothyroxine sodium (SYNTHROID); rosuvastatin (MANUFACTURER UNKNOWN), and unspecified multivitamins. The patient previously took povidone/iodine (BETADINE) on unknown dates for an unknown indication and experienced drug allergy. On 05Feb2021 at 21:00, the patient experienced fever, body aches, chills, bad headaches, and implanted breast skin became blotchy. On 07Feb2021, the patient's eyelids became puffy and eyes became glassy,. All the events were reported as serious for disability. The peak temperature was 101 degrees Fahrenheit on an unknown date in Feb2021. The patient contacted the doctor, eye care professional and hematologist/oncologist for the events. On 08Feb2021, the patient had a COVID-19 nasal swab PCR which was negative. The patient was not treated for the events. The clinical outcome of the fever was recovered on 12Feb2021; while that of the body aches, chills, bad headaches, implanted breast skin became blotchy, eyelids became puffy, and eyes became glassy were recovering.

Other Meds: SYNTHROID; ROSUVASTATIN

Current Illness:

ID: 1062226
Sex: M
Age:
State: MI

Vax Date: 02/09/2021
Onset Date: 02/10/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Bells Palsy; This is a spontaneous report from a contactable consumer (the patient). A 67-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot #: EM9810), via an unspecified route of administration, in the right arm (at the age of 67 years) on 09Feb2021 at 10:30 AM at single dose for COVID-19 immunization. The patient medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication taken within two weeks of vaccination included lisinopril (LISINOPRIL ACTAVIS), rosuvastatin, acetylsalicylic acid (ASPIRIN 81). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took Penicillin and experienced rash, Sulphamide and experienced nose bleed. On 10Feb2021 at 08:30 AM, the patient experienced Bell's Palsy. The patient visited the emergency room Therapeutic measures were taken as a result of Bell's Palsy and included tape left eye closed and use wetting gel. The clinical outcome of the bells palsy was not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.

Other Meds: LISINOPRIL ACTAVIS [LISINOPRIL]; ROSUVASTATIN; ASPIRIN 81

Current Illness:

ID: 1062227
Sex: F
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 03/01/2021
Hospital: Y

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: atrial fibrillation episode; This is a spontaneous report from a contactable consumer, the patient, from the Pfizer-sponsored program. A female patient of an unspecified age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. Medical history included heart problem and tachycardia. Concomitant medications included metoprolol succinate (MANUFACTURER UNKNOWN) for heart problem and tachycardia from an unknown date and unknown if ongoing. On an unknown date, 6 days after the first dose, the patient experienced atrial fibrillation episode which required hospitalization for a few days. The patient mentioned her medication was going to be changed to sotalol (MANUFACTURER UNKNOWN) due to the event (unspecified if treatment started). The clinical outcome of the atrial fibrillation episode was unknown. The patient also mentioned that nobody thought her experience was related to the Pfizer vaccine. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: The event atrial fibrillation episodes is attributed to an underlying medical condition and assessed unrelate to BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE0.

Other Meds: METOPROLOL SUCCINATE

Current Illness:

ID: 1062228
Sex: M
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Tested positive after the first dose; Tested positive after the first dose; This is a spontaneous report from a contactable consumer from a Pfizer-sponsored program. A male patient of an unspecified age received 1st dose of BNT162B2 (Pfizer/BioNTech COVID-19 Vaccine), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced tested positive after the first dose on an unspecified date. The patient underwent lab tests and procedures which included Covid test: positive on an unspecified date. The outcome of event was unknown. Information about batch/lot number requested.

Other Meds:

Current Illness:

ID: 1062229
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: tested positive for covid virus after first dose vaccine; tested positive for covid virus after first dose vaccine; This is a spontaneous report from a contactable consumer from a Pfizer Sponsored Program. A patient of unspecified age and gender received 1st dose of BNT162B2, via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was tested positive for covid virus after first dose vaccine. The patient underwent lab tests and procedures which included covid virus test: positive on an unspecified date. The outcome of event was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1062230
Sex: F
Age:
State: NJ

Vax Date: 02/11/2021
Onset Date: 02/11/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: whole body felt sore and exhausted; whole body felt sore and exhausted; bad cold/flu; bad cold/flu; little chest pain; minor fever; blood pressure dropped; dizziness; backpain; left arm felt sore; sleepy/light drowsiness; This is a spontaneous report from a contactable consumer (patient). A 30-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247), via an unspecified route of administration on the left arm on 11Feb2021 15:30 at a single dose (at the age of 30-years-old) for COVID-19 immunization. Medical history included >13 years ago: diagnosed TB with no symptom, completed TB treatment 1 year-plan and has issue no since then; >16 years ago: Hepatitis-b positive but received treatment and cleared out on diagnostics afterward. The patient was not pregnant. Concomitant medications were not reported. The patient had no COVID prior to vaccination. The patient has no known allergies. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247) on 21Jan2021 at 13:15 on the left arm at a single dose (at the age of 30-years-old) for COVID-19 immunization. After about 4.5h post-vaccination (20:00), her left arm felt sore and within the next 3h, she felt sleepy and experienced random light drowsiness. She woke up around 06:30 the next day (12Feb2021) only felt continued sore arm. However, at 08:30 to 09:30, her whole body felt sore and exhausted, especially back pain, as if she having a bad cold/flu. She also felt a little chest pain, had a minor fever and went sleeping from 12:00, woke up around 18:00-19:00. The whole body ache was almost gone but her back was still in pain and her blood pressure dropped with random dizziness when she was walking or standing up. The next morning (13Feb2021), the back pain was gone and she felt it back to normal except for a little random dizziness in movement. She did not take any medication to alleviate the adverse effects during the timeline. The patient was not COVID tested post vaccination. The patient recovered from back pain in 13Feb2021, the patient recovered from the remaining events in Feb2021.

Other Meds:

Current Illness:

ID: 1062231
Sex: F
Age:
State: OH

Vax Date: 02/13/2021
Onset Date: 02/13/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Achy right arm (site of injection) about 12 hours after injection; achy muscles all over body; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EM9809), via an unspecified route of administration on 13Feb2021 10:00 at single dose for covid-19 immunization. Vaccine location was right arm and it was the first dose. Patient is not pregnant at the time of vaccination. The facility type vaccine was Pharmacy or Drug Store. Patient was not diagnosed with COVID-19 prior to vaccination nor tested for COVID-19 since the vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. None medical history. Concomitant medication included omeprazole, fexofenadine hydrochloride (ALLEGRA). The patient experienced achy right arm (site of injection) about 12 hours after injection on 13Feb2021 21:30; achy muscles all over body about 16 hours after injection on 13Feb2021. Pain was relieved by taking two naproxen tablets. The outcome of events was recovered in Feb2021. The events were reported as non-serious.

Other Meds: OMEPRAZOLE; ALLEGRA

Current Illness:

ID: 1062232
Sex: F
Age:
State: CA

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Headache; left arm is hurting from the shoulder; tired; Nauseous; injection site pain; This is a spontaneous report from a contactable consumer (patient) and a contactable physician. A 64-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6201), via an unspecified route of administration at arm left on 09Feb2021 at 14:10 (at the age of 64 years) at single dose for COVID-19 immunization. Medical history included ongoing Crohn's disease, ongoing allergies, ongoing blood cholesterol abnormal. Concomitant medication included mesalamine (strength: 400 mg) oral at 400 mg twice daily for Crohn's disease, atorvastatin oral at 400 mg once a day for blood cholesterol abnormal, azathioprine oral at 50 mg twice daily for Crohn's disease, cetirizine oral at 10 mg for allergies, vitamin D at 1000 iU daily for supplementation, ketotifen fumarate (strength: 0.025 %) ophthalmic twice daily for allergies and ipratropium bromide (strength: 0.06%) nasal daily for allergies, all from an unknown date and ongoing. The patient experienced sore at the injection site on 09Feb2021, headache on the left side and her left arm was hurting from the shoulder down and she feels really tired and nauseous, all on 12Feb2021. The patient outcome of injection site pain was recovered on 09Feb2021; the outcome of the other events was not recovered. The information on the batch number has been requested.

Other Meds: MESALAMINE; ATORVASTATIN; AZATHIOPRINE; CETIRIZINE; VITAMIN D [VITAMIN D NOS]; KETOTIFEN FUMARATE; IPRATROPIUM BROMIDE

Current Illness: Allergy; Blood cholesterol abnormal; Crohn's disease

ID: 1062233
Sex: F
Age:
State:

Vax Date:
Onset Date: 02/11/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: touch of pneumonia; running a fever/temperature; running a fever/temperature; This is a spontaneous report from a contactable consumer (child of patient). An 88-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, on an unspecified date at a single dose for COVID-19 immunisation. Medical history included Alzheimer's. The patient's concomitant medications were not reported. The patient experienced running a fever/temperature and a touch of pneumonia on 11Feb2021. The clinical course was reported as follows: The day the patient was to go for her second dose, she was running a fever and was not able to go. The patient was diagnosed and had a touch of pneumonia. The patient was put on unspecified steroids and two unspecified antibiotics. The patient was running a temperature on an unspecified date but was better on 12Feb2021. Therapeutic measures were taken as a result of the events as aforementioned. The clinical outcome of running a fever and a touch of pneumonia was recovering.

Other Meds:

Current Illness:

ID: 1062234
Sex: U
Age:
State: CT

Vax Date:
Onset Date:
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Large lymph node swelling on left side of neck; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received bnt162b2 (UNSPECIFIED TRADE NAME, Solution for injection, lot/batch number and expiration date not provided), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced large lymph node swelling on left side of neck after use of product. Shot was in the left. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1062235
Sex: F
Age:
State: MI

Vax Date: 02/04/2021
Onset Date: 02/10/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Bell's palsy; This is a spontaneous report from a contactable healthcare professional reporting for herself. A 41-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number EL9269/expiration date: not provided), via an unspecified route of administration, on 04Feb2021 08:30 (at the age of 41 years old) as a single dose in the left arm for COVID-19 IMMUNIZATION. Relevant medical history included attention deficit hyperactivity disorder (ADHD). The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number EK9231/expiration date: not provided), via an unspecified route of administration, on 14Jan2021 at 08:45 (at the age of 41 years old) as a single dose in the left arm for COVID-19 IMMUNIZATION. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 10Feb2021, the patient experienced Bell's~ palsy. The event resulted in an emergency room/department or urgent care visit and received treatment which included CT scan, EKG, blood tests, and steroid prescribed. The outcome of the event Bell's palsy was not recovered. Since the vaccination, the patient had not been tested for COVID-19.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported event of Bell's palsy due to temporal relationship. However, the reported event may possibly represent intercurrent medical condition in this patient. There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, diagnostics including Head CT/MRI and viral serology, counteractive treatment measures and concomitant medications. This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: ADDERALL

Current Illness:

ID: 1062237
Sex: F
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: she had symptoms of a stroke; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program. An 81-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number and expiration date not provided) first dose, via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Initially, it was reported that the patient experienced symptoms of Bell's palsy before getting the second dose. It was further reported that the patient stated it was not true that she experienced Bell's palsy. She mentioned she had symptoms of a stroke on an unspecified date. She wanted to confirm that her appointment for next 20Feb2021 has not been cancelled. Consumer refused to continue with the survey. The outcome of the event was unknown. No follow-up attempts are possible; information about batch/lot number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1062238
Sex: F
Age:
State: MD

Vax Date: 02/08/2021
Onset Date: 02/09/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Increased blood pressure; Pain breathing; felt some discomfort in her hand; This is a spontaneous report from a contactable Physician. A 82-years-old female patient received the first dose of bnt162b2 (BNT162B2) vaccine , via an unspecified route of administration on 08Feb2021 at 0.3 mL, single for Covid-19 immunisation . Medical history included ongoing cardiac disorder (she has had five bypasses ten years ago) , ongoing lung disorder, ongoing osteoporosis , she has had three operations on her spinal cord. She has a neurologic compression fracture from ages ago , seasonal allergy, nitrate compound therapy, hypertension, anticoagulant therapy, electrolyte imbalance. Concomitant medication included ranolazine (RANEXA), isosorbide (ISOSORBIDE), gliclazide (DIAZIDE [GLICLAZIDE]), apixaban (ELIQUIS), magnesium (MAGNESIUM) , ubidecarenone (Q-10 CO-ENZYME). The patient experienced increased blood pressure on 09Feb2021 with outcome of not recovered , pain breathing on 09Feb2021 with outcome of not recovered , felt some discomfort in her hand on 09Feb2021 with outcome of unknown. The patient underwent lab tests and procedures which included blood pressure measurement: increased on 09Feb2021 166/100 and pulse 65. The 100 was alarming to her. The patient would notice the increase in blood pressure and pain breathing when walking longer distances Information on the lot/ batch number has been requested.

Other Meds: RANEXA; ISOSORBIDE; DIAZIDE [GLICLAZIDE]; ELIQUIS; MAGNESIUM; Q-10 CO-ENZYME

Current Illness: Cardiac disorder (Stated she has had five bypasses; this was ten years ago./cardiac issues); Osteoporosis (Verbatim: Osteoporosis); Pulmonary disorder (Verbatim: Pulmonary problems)

ID: 1062239
Sex: F
Age:
State: SC

Vax Date: 02/08/2021
Onset Date: 02/01/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Passed out; Constant running nose; Cough; bad cough; Sore throat; Diarrhea; This is a spontaneous report from a contactable consumer. A 72-years-old female patient received the second of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number: EL9267, Expiration Date May2021, via an unspecified route of administration on 08Feb2021 (at the age of 72 years old) as SINGLE DOSE in the left arm for COVID-19 vaccination. The patient's medical history and concomitant medications were not reported. Historical information included BNT162B2 dose 1 for COVID-19 vaccination.The patient developed the sore throat on 09Feb2021, Cough; bad cough on 10Feb2021, constant running nose on 11Feb2021. On 11Feb2021, the patient passed out in the bathroom floor, had an ambulance here. Patient still coughing a little, not as badly. The patient experienced diarrhea in Feb2021. Treatment for all events included cetirizine (ZYRTEC), Triamcinolone (NASACORT), pseudoephedrine (SUDAFED), dextromethorphan hydrobromide, guaifenesin, paracetamol, pseudoephedrine hydrochloride (DAYQUIL). Outcome of the events Passed out, Sore throat, Constant running nose, Diarrhea was unknown. Outcome of the events Cough; bad cough was not recovered

Other Meds:

Current Illness:

ID: 1062240
Sex: M
Age:
State: MA

Vax Date: 02/15/2021
Onset Date: 02/15/2021
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: chills; slight fever; flu like symptoms; minor headache; slight aching limbs; mild fatigue; This is a spontaneous report from a contactable consumer (patient). A 55-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: el3247), via an unspecified route of administration on 15Feb2021 11:45 at a single dose on left arm for COVID-19 immunization. The patient's medical history was not reported. The patient has no allergies to medications, food or other products. Concomitant medication included fluticasone propionate (FLOVENT). The patient previously received first dose of BNT162B2 on 26Jan2021 for COVID-19 immunization (lot number: el3247, administration time: 11:00 AM, vaccine location: left arm, dose number: 1). The patient did not receive any other vaccine within 4 weeks prior to COVID vaccine. On 15Feb2021 23:00, the patient experienced chills, slight fever, slight aching limbs, minor headache (would describe as flu like symptoms) occurred 10 hours post injection with mild fatigue during course of following day. The events were reported as non-serious. No treatment was received for the adverse events. The patient was recovering from the events. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination.

Other Meds: FLOVENT

Current Illness:

ID: 1062241
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 03/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: arm soreness; more discomfort than I usually have for vaccine; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (Age: 73; Unit: Unknown) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization and apixaban (ELIQUIS), via an unspecified route of administration from an unspecified date at an unknown dose and frequency as blood thinner. The patient medical history and concomitant medications were not reported. It was reported that the patient got her first dose of BNT162B2 and experience arm soreness on the second day, more discomfort than she usually have for vaccine. By the third day, the patient was fine, and reported that "it went away". The patient stated that "they have to give me a 2nd shot, right? since I'm on a blood thinner". The outcome of the events was recovered on an unspecified date. The action taken in response to the events for apixaban was unknown. Information about lot/batch number has been requested.

Other Meds: Eliquis

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm